We are live on ! Find out more
EARNEST Partners

EARNEST Partners Portfolio holdings

AUM $24.3B
1-Year Est. Return 34.41%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+34.41%
3 Year Est. Return
+66.51%
5 Year Est. Return
+86.35%
10 Year Est. Return
+426.93%
AUM
$17.9B
AUM Growth
+$600M
Cap. Flow
+$24.4M
Cap. Flow %
0.14%
Top 10 Hldgs %
15.34%
Holding
1,185
New
13
Increased
112
Reduced
147
Closed
10

Top Buys

Rank Stock Value
1
TNET icon
TriNet
TNET
+$101M
2
NSP icon
Insperity
NSP
+$99.5M
3
HP icon
Helmerich & Payne
HP
+$77.1M
4
QGEN icon
Qiagen
QGEN
+$64M
5
SON icon
Sonoco
SON
+$42.2M

Sector Composition

Rank Sector Weight
1 Industrials 22.5%
2 Technology 20.45%
3 Financials 16.44%
4 Consumer Discretionary 11.88%
5 Healthcare 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLK icon
351
Blackrock
BLK
$167B
$50.5K ﹤0.01%
73
ADI icon
352
Analog Devices
ADI
$172B
$47.9K ﹤0.01%
246
HZO icon
353
MarineMax
HZO
$748M
$47.8K ﹤0.01%
1,400
BX icon
354
Blackstone
BX
$104B
$47.7K ﹤0.01%
513
C icon
355
Citigroup
C
$213B
$47.6K ﹤0.01%
1,033
MDLZ icon
356
Mondelez International
MDLZ
$82.9B
$46.6K ﹤0.01%
639
HNRG icon
357
Hallador Energy
HNRG
$646M
$46.1K ﹤0.01%
5,385
AG icon
358
First Majestic Silver
AG
$7.52B
$45.8K ﹤0.01%
8,100
PLD icon
359
Prologis
PLD
$136B
$44.5K ﹤0.01%
363
HCA icon
360
HCA Healthcare
HCA
$88.4B
$44.3K ﹤0.01%
146
GBX icon
361
The Greenbrier Companies
GBX
$1.57B
$43.1K ﹤0.01%
1,000
MO icon
362
Altria Group
MO
$125B
$42.6K ﹤0.01%
940
LRCX icon
363
Lam Research
LRCX
$316B
$41.8K ﹤0.01%
650
MRSH
364
Marsh
MRSH
$94.3B
$41.4K ﹤0.01%
220
OVV icon
365
Ovintiv
OVV
$17B
$41.3K ﹤0.01%
1,086
CVS icon
366
CVS Health
CVS
$135B
$41.3K ﹤0.01%
597
ITW icon
367
Illinois Tool Works
ITW
$84.1B
$40.8K ﹤0.01%
163
FLWS icon
368
1-800-Flowers.com
FLWS
$252M
$40.6K ﹤0.01%
5,200
ZTS icon
369
Zoetis
ZTS
$32.7B
$40K ﹤0.01%
232
ETN icon
370
Eaton
ETN
$141B
$39.8K ﹤0.01%
198
WLFC icon
371
Willis Lease Finance
WLFC
$1.65B
$39.1K ﹤0.01%
3,000
VRTX icon
372
Vertex Pharmaceuticals
VRTX
$123B
$39.1K ﹤0.01%
111
ANIK icon
373
Anika Therapeutics
ANIK
$215M
$39K ﹤0.01%
1,500
TMUS icon
374
T-Mobile US
TMUS
$195B
$38.8K ﹤0.01%
279
SCHW
375
Charles Schwab
SCHW
$182B
$38.7K ﹤0.01%
682

Similar funds

EARNEST Partners's Q2 2023 Portfolio in Review

As of Q2 2023, EARNEST Partners held 1,185 positions worth $17.9B, up 3.5% from $17.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 1.9%. EARNEST Partners opened 13 new positions and exited 10, leaving the 1,185-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 22% a quarter earlier, followed by Technology and Financials.

  • EARNEST Partners's largest Q2 2023 buy was TriNet: 1,113,592 shares worth $106M.
  • EARNEST Partners added most to Helmerich & Payne in Q2 2023, an estimated $77.1M increase.
  • EARNEST Partners's biggest Q2 2023 reduction was Syneos Health, Inc. Class A Common Stock, cutting an estimated $105M.
  • EARNEST Partners fully exited ABB Ltd in Q2 2023, selling an estimated $373K.
  • EARNEST Partners's ten largest holdings make up 15% of its $17.9B portfolio in Q2 2023.
  • EARNEST Partners opened 13 new positions and closed 10 in Q2 2023.
  • EARNEST Partners's portfolio value rose 3.5% quarter-over-quarter to $17.9B.

Based on EARNEST Partners's 13F filing for Q2 2023, filed 7 Aug 2023.